MedTrace Logo

Safety and Efficacy Evaluation of the Ivory Dentin Graft Device

NCT03150472 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 43

Last updated 2020-09-11

No results posted yet for this study

Summary

Ivory Dentin Graft is at least as good as the competitor treatment group (OsteoBiol Gen Os) for alveolar ridge preservation following tooth extraction.

The non-inferiority endpoints will be achieved if the competitor treatment group will not be statistically better than the Ivory Graft treatment.

Conditions

  • Deficiency of Alveolar Ridge (Disorder)
  • Alveolar Bone Grafting
  • Mandibular Prosthesis User

Interventions

DEVICE

Graft Matrix

Both Graft matrix products are supplied sterile, for single use only and packed in vials or a syringe-like applicator. All products consist of the same bone graft particles with the only variants being due to different amounts per package or different containers.

Sponsors & Collaborators

  • Ivory Graft Ltd.

    lead INDUSTRY

Principal Investigators

  • Tal Lavi, PhD · Ivory Graft Ltd.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-11-07
Primary Completion
2020-09-09
Completion
2020-09-09

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03150472 on ClinicalTrials.gov